These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25423119)

  • 21. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
    Slaughter MS; Naka Y; John R; Boyle A; Conte JV; Russell SD; Aaronson KD; Sundareswaran KS; Farrar DJ; Pagani FD
    J Heart Lung Transplant; 2010 Jun; 29(6):616-24. PubMed ID: 20400335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous right ventricular assist device as support for cardiogenic shock due to right ventricular infarction.
    Prutkin JM; Strote JA; Stout KK
    J Invasive Cardiol; 2008 Jul; 20(7):E215-6. PubMed ID: 18599906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of anti-Xa and activated partial thromboplastin time monitoring for heparin dosing in patients with cirrhosis.
    Fuentes A; Gordon-Burroughs S; Hall JB; Putney DR; Monsour HP
    Ther Drug Monit; 2015 Feb; 37(1):40-4. PubMed ID: 24901494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Placement of the TandemHeart percutaneous left ventricular assist device.
    Pretorius M; Hughes AK; Stahlman MB; Saavedra PJ; Deegan RJ; Greelish JP; Zhao DX
    Anesth Analg; 2006 Dec; 103(6):1412-3. PubMed ID: 17122214
    [No Abstract]   [Full Text] [Related]  

  • 25. Percutaneous ventricular assist device in hypertrophic obstructive cardiomyopathy with cardiogenic shock: bridge to myectomy.
    Cevik C; Nguyen HU; Civitello AB; Simpson L
    Ann Thorac Surg; 2012 Mar; 93(3):978-80. PubMed ID: 22364991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The successful application of a heparin nomogram in a community hospital.
    Hollingsworth JA; Rowe BH; Brisebois FJ; Thompson PR; Fabris LM
    Arch Intern Med; 1995 Oct; 155(19):2095-100. PubMed ID: 7575069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful conversion of TandemHeart left ventricular assist device to right ventricular assist device after implantation of a HeartMate XVE.
    Takagaki M; Wurzer C; Wade R; Lee R; Malaisrie SC; McCarthy PM; McGee EC
    Ann Thorac Surg; 2008 Nov; 86(5):1677-9. PubMed ID: 19049776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticoagulation for Percutaneous Ventricular Assist Device-Supported Cardiogenic Shock: JACC Review Topic of the Week.
    Vandenbriele C; Arachchillage DJ; Frederiks P; Giustino G; Gorog DA; Gramegna M; Janssens S; Meyns B; Polzin A; Scandroglio M; Schrage B; Stone GW; Tavazzi G; Vanassche T; Vranckx P; Westermann D; Price S; Chieffo A
    J Am Coll Cardiol; 2022 May; 79(19):1949-1962. PubMed ID: 35550692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticoagulation of a Percutaneous Left Ventricular Assist Device Using a Low-Dose Heparin Purge Solution Protocol: A Case Series.
    Newsome AS; Taylor A; Garner S
    J Pharm Pract; 2020 Aug; 33(4):471-476. PubMed ID: 30614366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perioperative use of TandemHeart percutaneous ventricular assist device in surgical repair of postinfarction ventricular septal defect.
    Gregoric ID; Kar B; Mesar T; Nathan S; Radovancevic R; Patel M; Loyalka P
    ASAIO J; 2014; 60(5):529-32. PubMed ID: 25010911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of Anticoagulation with Impella® Percutaneous Ventricular Assist Devices and Review of New Literature.
    Succar L; Sulaica EM; Donahue KR; Wanat MA
    J Thromb Thrombolysis; 2019 Aug; 48(2):284-291. PubMed ID: 30877619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin dosing in critically ill patients undergoing therapeutic hypothermia following cardiac arrest.
    Wahby KA; Jhajhria S; Dalal BD; Soubani AO
    Resuscitation; 2014 Apr; 85(4):533-7. PubMed ID: 24361456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Which is better: a miniaturized percutaneous ventricular assist device or extracorporeal membrane oxygenation for patients with cardiogenic shock?
    Chamogeorgakis T; Rafael A; Shafii AE; Nagpal D; Pokersnik JA; Gonzalez-Stawinski GV
    ASAIO J; 2013; 59(6):607-11. PubMed ID: 24088905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.
    Cheng JM; den Uil CA; Hoeks SE; van der Ent M; Jewbali LS; van Domburg RT; Serruys PW
    Eur Heart J; 2009 Sep; 30(17):2102-8. PubMed ID: 19617601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activated clotting time differential is a superior method of monitoring anticoagulation following coronary angioplasty.
    Pitney MR; Kelly SA; Allan RM; Giles RW; McCredie M; Walsh WF
    Cathet Cardiovasc Diagn; 1996 Feb; 37(2):145-50. PubMed ID: 8808069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement in survival after mechanical circulatory support with pneumatic pulsatile ventricular assist devices in pediatric patients.
    Hetzer R; Potapov EV; Stiller B; Weng Y; Hübler M; Lemmer J; Alexi-Meskishvili V; Redlin M; Merkle F; Kaufmann F; Hennig E
    Ann Thorac Surg; 2006 Sep; 82(3):917-24; discussion 924-5. PubMed ID: 16928509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole blood hypercoagulability despite anticoagulation during mechanical cardiac assist.
    Niemi TT; Kukkonen SI; Hämmäinen PT; Suojaranta-Ylinen RT; Sipponen JT
    Perfusion; 2008 Mar; 23(2):107-10. PubMed ID: 18840579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous left ventricular assist device, TandemHeart, for high-risk percutaneous coronary revascularization. A single centre experience.
    Giombolini C; Notaristefano S; Santucci S; Fortunati F; Savino K; Sindaco FD; Ragni T; Allegri M; Ambrosio G
    Acute Card Care; 2006; 8(1):35-40. PubMed ID: 16720426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subcutaneous low molecular weight heparin for management of anticoagulation in infants on excor ventricular assist device.
    Ghez O; Liesner R; Karimova A; Ng C; Goldman A; van Doorn C
    ASAIO J; 2006; 52(6):705-7. PubMed ID: 17117062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dermatan sulfate: an alternative to unfractionated heparin for anticoagulation in hemodialysis patients.
    Vitale C; Berutti S; Bagnis C; Soragna G; Gabella P; Fruttero C; Marangella M
    J Nephrol; 2013; 26(1):158-63. PubMed ID: 22419236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.